EquitySectoral/ ThematicRegularGrowthVery High

Bandhan Healthcare Fund

Q: What is the NAV of Bandhan Healthcare Fund?

As of 05 Oct 2026, the NAV of Bandhan Healthcare Fund is ₹10.81 per unit. NAV (net asset value) is the fund's per-unit price, published once each business day.

Q: What returns has Bandhan Healthcare Fund delivered?

Bandhan Healthcare Fund has returned +8.61% per year since inception. Figures beyond one year are annualised (CAGR) and are computed from AMFI NAV history, so they may differ slightly from other portals.

Q: What is the expense ratio of Bandhan Healthcare Fund?

Bandhan Healthcare Fund charges an expense ratio of 2.78% per year. This annual fee is already deducted from the NAV, so the returns you see are net of it.

Q: What are the top holdings of Bandhan Healthcare Fund?

Bandhan Healthcare Fund's largest holdings are Sun Pharmaceutical Industries Limited (10.5%), Cipla Limited (6.4%), Max Healthcare Institute Limited (5.8%), Apollo Hospitals Enterprise Limited (5.6%) and Divi's Laboratories Limited (4.3%). Holdings are disclosed monthly and change over time.

Q: How risky is Bandhan Healthcare Fund?

Bandhan Healthcare Fund is rated very high on SEBI's risk-o-meter, its trailing-3Y volatility (annualised) is 12.7% and its worst peak-to-trough fall in our sample was -8.9%. Higher volatility means the NAV swings more; the drawdown shows how far it has fallen from a peak historically.

Q: What is the benchmark of Bandhan Healthcare Fund?

Bandhan Healthcare Fund is benchmarked against the BSE Healthcare TRI. Its alpha and beta on this page are measured against that index.

Q: Who manages Bandhan Healthcare Fund?

Bandhan Healthcare Fund is managed by Viraj Kulkarni, Brijesh Shah, Ritika Behera and Gaurav Satra at Bandhan.

Q: How is Bandhan Healthcare Fund taxed?

Bandhan Healthcare Fund is an equity-oriented fund, so its capital gains get concessional rates: short-term gains (units held under 1 year) are taxed at 20%, and long-term gains (held 1 year or more) at 12.5% above a ₹1.25 lakh per-year exemption. These rates apply on redemption and don't add to your income-tax slab.

Bandhan Mutual Fund · Best Sectoral & Thematic Mutual Funds

NAV

₹10.81

-1.02% 1D

as of 05 Oct 2026

This is the Regular plan of Bandhan Healthcare Fund — bought through a distributor, whose commission is paid out of its expense ratio. Income is retained in the fund, so it shows up as NAV rather than as a payout.

Compare SIP calculator

Performance

+8.61%absolute

52-week rangePrev NAV ₹10.92

Latest ₹10.81

Low ₹9.0774th percentile of its 52-week rangeHigh ₹11.43

Scorecard

Not rated

How this is computed

Each verdict is computed from this fund's own metrics against its sub-category — the number behind it is shown, not a black-box rating. Not rated — this fund has no full year of NAV history yet. A rating needs at least a 1-year return to rank its performance against peers.

Performance—

Not enough Sectoral/ Thematic peers to rank yet

RiskLow

Volatility 12.7% vs 15.6% category avg

CostHigh

2.8% expense vs 2.5% category avg

Consistency—

Not enough history for a rolling 3Y view

Strengths & concerns

Generated from this fund's own numbers against its sub-category — each point names the figure behind it.

Strengths

Ahead of the Sectoral/ Thematic average on 1M/3M/6M
Less volatile than its Sectoral/ Thematic peers (12.7% vs 15.6%)

Concerns

High expense ratio (2.78%) vs the Sectoral/ Thematic average of 2.46%

Key Metrics

Annual fee charged by the fund, already deducted from NAV

2.78%

Category 2.46%▲0.32%

Portfolio-weighted harmonic mean P/E across the fund's equity holdings

39.77

Category —

Excess return per unit of total volatility (rf = 6.5%)

—

Category 0.36

Scheme Info

Definitions

Plan

Regular · Growth

Period before units can be redeemed — 3 years for ELSS, none for most open-ended funds

None

• If redeemed/switched out on or within 30 days from the date of allotment: 0.50% of the applicable NAV • If redeemed/switched out after 30 days from date of allotment – Nil

Up to 0.50%

tiered — see the full terms

Statutory levy on every mutual-fund purchase since 1 Jul 2020 (SEBI / Govt of India) — the same for every scheme

0.005%

SIP Inv.

Allowed

Smallest recurring SIP instalment the scheme accepts

₹100

Smallest one-time (lumpsum) investment the scheme accepts

₹1,000

BSE Healthcare TRI

Start of our NAV history for this plan. Direct plans begin 1 Jan 2013, so this is the plan's inception — not necessarily the scheme's original launch date.

02 Dec 2025

Period returns (<1Y, absolute — not annualized)

Definitions

Absolute return over the last 1 month (not annualized)

-3.65%

Absolute return over the last 3 months (not annualized)

-0.49%

Absolute return over the last 6 months (not annualized)

+18.46%

Absolute return since 1 Jan of this year (not annualized)

+10.49%

Annualized returns (≥1Y — CAGR)

Definitions

1-year point-to-point return, annualized (CAGR)

—

3-year annualized return (CAGR)

—

5-year annualized return (CAGR)

—

10-year annualized return (CAGR)

—

Annualized return (CAGR) since the first NAV we hold for this plan — the Inception date under Key metrics. AMFI's history starts in April 2006, so an older scheme is measured from there.

+8.61%

Advanced metrics — risk and benchmark ratios

Risk (trailing 3Y)

Definitions

Annualized standard deviation of daily returns

12.65%

Excess return per unit of total volatility (rf = 6.5%)

—

Excess return per unit of downside deviation — upside swings aren't penalized (rf = 6.5%)

—

Largest peak-to-trough decline over full history

-8.92%

Benchmark ratios (vs Nifty 500 TRI · 36 monthly returns)

Definitions

Jensen's alpha (annualized): return above what CAPM predicts for the fund's beta vs Nifty 500 TRI

—

Sensitivity to Nifty 500 TRI moves; 1 = moves with the index

—

How much of the fund's movement Nifty 500 TRI explains

—

Excess return per unit of beta (market risk)

—

Active return over the benchmark per unit of tracking error

—

Annualized std dev of fund-minus-benchmark returns

—

Fund's share of benchmark gains in up months (100 = matches index)

—

Fund's share of benchmark losses in down months (lower is better)

—

Computed vs the Nifty 500 TRI over the last 36 complete months — the closest match to this fund's mandate. TRI means dividends reinvested, as they are in the fund's own NAV; ₹ means a US index converted at each day's USD/INR, since the fund is priced in rupees. Needs ~3 years of history; a low R² means the fund tracks the index loosely.

Fund vs category average (Sectoral/ Thematic)

Period	Fund	Category avg.	Diff
1M abs	-3.65%	-4.57%	+0.92%
3M abs	-0.49%	-2.62%	+2.13%
6M abs	+18.46%	+11.37%	+7.09%
1Y CAGR	—	+2.14%	—
3Y CAGR	—	+12.50%	—
5Y CAGR	—	+10.82%	—

Category average across peers in Sectoral/ Thematic (up to 255 funds with data), same plan and option, excluding this fund. Under-1-year figures are absolute; 1Y and beyond are annualised (CAGR).

Not sure what a figure means? The glossary explains every metric, and the methodology shows the formulas.

Backtest this fund

What a SIP or one-time investment would have grown to over this fund’s real NAV history.

Monthly investment (₹)

Period

Invested

₹1.00L

Current value

₹1.06L

Absolute

+6.48%

XIRR

+17.91%

Value vs. invested

ValueInvested

10 monthly installments of ₹10,000 into Bandhan Healthcare Fund, valued at the latest NAV. XIRR annualizes for each installment’s timing.

Calendar-year returns

What the fund actually returned in each year, not the smoothed average.

Year	Fund	Nifty 500 TRI	Diff
2026part	+10.49%	-7.18%	+17.67%
2025part	-1.71%	—	—

January–December, from this fund's NAV history. Absolute return, not annualised. “part” marks a year the fund didn't run end to end — its first year, the current year so far, or one it stopped reporting in; those years show no benchmark comparison.

Recent changes

Expense-ratio, fund-manager, exit-load and minimum-investment changes we've picked up in the last 30 days.

Expense ratio down: 2.83% → 2.78%
05 Oct 2026

History points

211

Expense ratio

2.78%

AUM

₹301.31Cr

Exit load

• If redeemed/switched out on or within 30 days from the date of allotment: 0.50% of the applicable NAV • If redeemed/switched out after 30 days from date of allotment – Nil

Portfolio, AUM & scheme details shown from another plan of this scheme (same underlying portfolio).

P/E ratio

39.8

P/B ratio

7.3

Avg market cap

₹1,10,575Cr

P/E & P/B are portfolio-weighted harmonic means across 29 of 35 equity holdings (88% of the portfolio); loss-making companies are excluded.

Taxation

Taxed as equity

This is an equity-oriented fund (≥65% in Indian equities), so gains get the concessional capital-gains rates below — they do not add to your income-tax slab.

Short-term (STCG)

20%

Held under 1 year

Flat, on the whole gain

Long-term (LTCG)

12.5%

Held 1 year or more

On gains above ₹1.25 L per financial year

Applies to capital gains on redemption. Excludes IDCW/dividend tax, STT, surcharge and cess, and pre-2018 equity grandfathering. For research only — consult a tax advisor before filing.

Peer comparison · Sectoral/ Thematic

Compare all


Bandhan Healthcare FundThis fund Bandhan · Regular · Growth	—	—	—	—	—	2.78%	₹301.31Cr
Nippon India Taiwan Equity Fund Nippon India · Regular · Growth	★★★★☆	+125.07%	+61.55%	—	—	2.34%	₹1,110Cr
HDFC Defence Fund HDFC · Regular · Growth	★★★★☆	+19.02%	+34.59%	—	—	1.79%	₹9,371Cr
HDFC Pharma and Healthcare Fund HDFC · Regular · Growth	★★★★★	+24.17%	+28.28%	—	—	2.11%	₹2,282Cr
Franklin Asian Equity Fund Franklin Templeton · Regular · Growth	★★★☆☆	+31.28%	+23.90%	+8.86%	—	2.47%	₹720.84Cr
Nippon India Japan Equity Fund Nippon India · Regular · Growth	★★★☆☆	+28.99%	+22.97%	+10.76%	—	2.50%	₹330.20Cr

Market-cap allocation · AMFI bands, Jul 2026

Equity holdings by company size — 100% of the equity sleeve priced.

Large cap34.3%
Mid cap36.1%
Small cap29.6%

Asset allocation

As on 31 Aug 2026 · AMC disclosure

Equity95.97%
Cash & Equivalents4.03%

which companies this fund invests in

As on 31 Aug 2026 · AMC disclosure

Sun Pharmaceutical Industries Limited

10.48%

Cipla Limited

6.38%

Max Healthcare Institute Limited

5.81%

Apollo Hospitals Enterprise Limited

5.64%

Divi's Laboratories Limited

4.28%

Aurobindo Pharma Limited

4.14%

Lupin Limited

3.96%

Shilpa Medicare Limited

3.72%

GlaxoSmithKline Pharmaceuticals Limited

3.68%

Dr. Reddy's Laboratories Limited

3.48%

Holds the same stocks as (by portfolio overlap, not by category)

Compare the top 3 →

Fund	Overlap	Rating	TER	3Y
Bandhan BSE Healthcare Index Fund Bandhan · Index Funds	60.6%	★★★★★	0.34%	—
Nippon India Pharma Fund Nippon India · Sectoral/ Thematic	58.4%	★★★★☆	1.00%	+17.83%
ITI Pharma and Healthcare Fund ITI · Sectoral/ Thematic	57.8%	★★★★★	0.89%	+19.16%
DSP Nifty Healthcare Index Fund DSP · Index Funds	56.4%	★★★★★	0.40%	—
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Edelweiss · Index Funds	52.2%	★★★★★	0.55%	+18.52%
Mirae Asset Healthcare Fund Mirae Asset · Sectoral/ Thematic	51.7%	★★★★★	0.62%	+22.23%
UTI - Healthcare Fund UTI · Sectoral/ Thematic	51.5%	★★★★☆	1.34%	+22.90%
HDFC Pharma and Healthcare Fund HDFC · Sectoral/ Thematic	51.4%	★★★★★	1.03%	+29.81%

Overlap is the share of each fund's equity book invested in the same stocks, by weight, across the Direct-plan universe — so a fund that is only part equity is labelled as such. ! marks a pair holding more in common than nine pairs in ten of its type, where that type has a measured distribution.

🚩Holdings under NSE surveillance (ASM)

1 holding — 3.72% of the portfolio — sit in stocks NSE currently lists under its Additional Surveillance Measure. ASM is an exchange response to unusual price or volume activity (higher margins, and trade-for-trade settlement at stage II), not a view on the company or on this fund.

Shilpa Medicare LimitedLong-term · Stage I3.72%

Source: NSE ASM list, matched to holdings by company name — a holding whose name differs from NSE's spelling may not be matched. BSE's separate list is not covered.

Worst falls, and the wait to get back

How far this fund has dropped from a high, and how long it took to reclaim it.

-8.9%04 Dec 2025 → 29 Jan 2026
Fell over 2 months, back to the old high on 06 May 2026 — 3 months under water after the low.
-5.4%31 Aug 2026 → 05 Oct 2026
Still below that high — 35 days down, and no recovery yet.

Measured on this fund’s own NAV history, peak to trough to the day it regained the peak. Falls shallower than 5% are left out. A recovery date is when the NAV got back, not when any particular investor did — that depends on when they bought.

Fund size over time

Quarterly average AUM · AMFI

₹301.31Cr

April - June 2026

+5%

since January - March 2026

−₹11.74Cr

est. net flow, last quarter

At or near its largest, ₹301.31Cr in April - June 2026. Size matters most where the mandate is narrow — a large small-cap or a very large flexi-cap book is harder to move without moving the price.

Net flow is an estimate: AMFI publishes a quarterly average AUM, not a closing balance, and it covers every plan and option of this scheme together, so it is a read on direction and rough size rather than a cash-flow statement.

AMC Profile

Bandhan Mutual Fund is the former IDFC Mutual Fund, bought in 2022 by a consortium of Bandhan Financial Holdings, ChrysCapital and GIC and renamed the following year. It carries a long-established debt franchise alongside its equity and index schemes.

Launched

19 Dec 1999

Total AUM

₹2,04,046Cr+4.5% QoQ

Avg AUM · April - June 2026

Website

bandhanmutual.com

Fund Managers

VKViraj KulkarniStart date not disclosed

Role

Vice President B.Tech. – Equity Fund Management

Education

CFA, (Finance), B.Tech. (Electronics) Fund

Experience

He is associated with Bandhan PGDM AMC since September 2015 and is the dedicated fund manager for foreign securities since Fund - Equity portion, March 2016. He also undertakes equity research. Prior experience: Franklin Templeton Asset Management (India) Pvt. Ltd. as Management Trainee (May 2014 – September 2015). Goldman Sachs Services India as an Analyst for Wealth Management Technology (June 2010 – May 2012). (Total experience - 12 years)

Funds managed (8)

All schemes Viraj Kulkarni runs →

BSBrijesh ShahStart date not disclosed

Role

Senior Vice President – Fixed Income

Education

Post Graduate Diploma in Finance

Experience

Mr Shah is associated with Bandhan AMC since August 2015 as part of the Fixed Income Team and will now be handling investments and fixed income Bandhan US Treasury Bond 0-1 year – fund management. Prior experience: · IDBI Asset Management Ltd. – Dealing in Fixed income (Jan.2013 to Aug.2015) · India Bulls Asset Management Ltd. – Dealing in Fixed income (Jun.2011 to Dec.2012) · Mata Securities - Relationship Manager, Wholesale Debt Market (Jun.2010 to Jun.2011) · Twenty First Century - Relationship Manager, Wholesale Debt Market (Jan.2009 to May2010) (Total experience – 15 years)

Funds managed (42)

All schemes Brijesh Shah runs →

RBRitika BeheraStart date not disclosed

Role

Vice President MBA -Equities

Education

(Finance), Bcom

Experience

Ms. Ritika Behera has joined Bandhan AMC Limited as Vice President – Equity Equities on August 10, 2023 in Equity Investments team. In her role she will be US Equity responsible for research and analysis. Prior to Bandhan AMC Limited, she was associated with Ocean Dial Asset Equity portion management from April 2021 to July 2023 as Analyst. Earlier to this, she was and all other schemes associated with Elara Securities Pvt having Limited from January 2017 to March 2021 and Batlivala & Karani Securities Pvt Ltd from August 2013 to January 2017. (Total experience – 14 years)

Funds managed (21)

All schemes Ritika Behera runs →

GSGaurav SatraStart date not disclosed

Role

Deputy Manager – Accountant, Fund Management – Equity

Education

Chartered B.Com

Experience

Mr. Gaurav Satra joined the Bandhan US Equity Fund of Equity Fund Management Fund team of Bandhan AMC in having provision for investment June 2022 and was in overseas securities in equity co-managed designated as the Equity segment. Dealer.Prior to the same, he was associated with various Consultancy Firms as a CA from December 2016 to May 2022. (Total experience – 8.5 years)

Funds managed (21)

All schemes Gaurav Satra runs →

Fund managers from the AMC's filed Scheme Summary — its most recent filing for this scheme. Benchmark and dealing terms from it and this scheme's SEBI-filed Scheme Information Document on AMFI. Each manager's qualifications and role are reconciled across every filing this fund house makes for them, including its Statement of Additional Information. Total AUM via AMFI.

Explore from here

Fund managers

Viraj Kulkarni Brijesh Shah Ritika Behera Gaurav Satra

Top holdings

Sun Pharmaceutical Industries Limited Cipla Limited Max Healthcare Institute Limited Apollo Hospitals Enterprise Limited Divi's Laboratories Limited Aurobindo Pharma Limited Lupin Limited Shilpa Medicare Limited GlaxoSmithKline Pharmaceuticals Limited Dr. Reddy's Laboratories Limited Torrent Pharmaceuticals Limited Gland Pharma Limited

Bandhan in the news

Headlines about the fund house, not this scheme in particular — highlights only; tap through to read the full story at the source.

Run SIP calculator Add to compare

Returns and risk are computed from NAV history and may differ slightly from other portals due to methodology (rolling vs point-to-point, dividend treatment). For research only — not investment advice.

About Sectoral & Thematic funds

Sectoral and thematic funds must keep at least 80% in the equity of one sector (banking, pharma, technology) or one theme (consumption, manufacturing, ESG). That concentration is the point and the risk: with no mandate to diversify away from the sector, the fund rises and falls with it.

Frequently asked questions

What is the NAV of Bandhan Healthcare Fund?

As of 05 Oct 2026, the NAV of Bandhan Healthcare Fund is ₹10.81 per unit. NAV (net asset value) is the fund's per-unit price, published once each business day.

What returns has Bandhan Healthcare Fund delivered?

Bandhan Healthcare Fund has returned +8.61% per year since inception. Figures beyond one year are annualised (CAGR) and are computed from AMFI NAV history, so they may differ slightly from other portals.

What is the expense ratio of Bandhan Healthcare Fund?

Bandhan Healthcare Fund charges an expense ratio of 2.78% per year. This annual fee is already deducted from the NAV, so the returns you see are net of it.

What are the top holdings of Bandhan Healthcare Fund?

Bandhan Healthcare Fund's largest holdings are Sun Pharmaceutical Industries Limited (10.5%), Cipla Limited (6.4%), Max Healthcare Institute Limited (5.8%), Apollo Hospitals Enterprise Limited (5.6%) and Divi's Laboratories Limited (4.3%). Holdings are disclosed monthly and change over time.

How risky is Bandhan Healthcare Fund?

Bandhan Healthcare Fund is rated very high on SEBI's risk-o-meter, its trailing-3Y volatility (annualised) is 12.7% and its worst peak-to-trough fall in our sample was -8.9%. Higher volatility means the NAV swings more; the drawdown shows how far it has fallen from a peak historically.

What is the benchmark of Bandhan Healthcare Fund?

Bandhan Healthcare Fund is benchmarked against the BSE Healthcare TRI. Its alpha and beta on this page are measured against that index.

Who manages Bandhan Healthcare Fund?

Bandhan Healthcare Fund is managed by Viraj Kulkarni, Brijesh Shah, Ritika Behera and Gaurav Satra at Bandhan.

How is Bandhan Healthcare Fund taxed?

Bandhan Healthcare Fund is an equity-oriented fund, so its capital gains get concessional rates: short-term gains (units held under 1 year) are taxed at 20%, and long-term gains (held 1 year or more) at 12.5% above a ₹1.25 lakh per-year exemption. These rates apply on redemption and don't add to your income-tax slab.